The complications of diuretic therapy in patients with cirrhosis.
D000471:Alkalosis / Q000139:chemically induced; D001201:Ascites / Q000188:drug therapy*; D001806:Blood Urea Nitrogen; D002740:Chlorothiazide / Q000009:adverse effects*; D004976:Ethacrynic Acid / Q000009:adverse effects*; D005665:Furosemide / Q000009:adverse effects*; D006501:Hepatic Encephalopathy / Q000139:chemically induced*; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D007010:Hyponatremia / Q000139:chemically induced*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D013148:Spironolactone / Q000009:adverse effects*
D013148:Spironolactone; D002740:Chlorothiazide; D005665:Furosemide; D004976:Ethacrynic Acid